Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
5,887.75
-8.50(-0.14%)
Dow Futures
43,135.00
-42.00(-0.10%)
Nasdaq Futures
20,473.75
-45.75(-0.22%)
Russell 2000 Futures
2,250.50
-5.00(-0.22%)
Crude Oil
70.27
-0.29(-0.41%)
Gold
2,742.80
+3.90(+0.14%)

Corvus Pharmaceuticals, Inc. (C17.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Follow

6.58

-0.01

(-0.15%)

At close: 09:01AM CEST

Loading interactive chart...

Simply Wall St.
Insiders of Corvus Pharmaceuticals Getting Good Value On Their US$1.03m Investment
Last week, Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) insiders, who had purchased shares in the previous 12 months...
Zacks
Corvus Stock Up on Initiation of Phase III Lymphoma Study on Lead Drug
CRVS stock gains 14% on initiating a registrational study on its lead candidate, soquelitinib, to treat relapsed/refractory peripheral T-cell lymphoma.